Adial Pharmaceuticals Inc (ADIL) — Financial Flexibility Index
Adial Pharmaceuticals Inc (ADIL) has a Financial Flexibility Index of -1.07x as of March 2026. Free cash flow of $-1.61 Million (operating CF $-1.61 Million minus capex $0.00) represents -1% of total liabilities ($1.51 Million). Check ADIL tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Adial Pharmaceuticals Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Adial Pharmaceuticals Inc across 11 annual periods. For the full cash flow conversion analysis, see Adial Pharmaceuticals Inc cash conversion from operations.
Annual Financial Flexibility Index for Adial Pharmaceuticals Inc (2015–2025)
Year-by-year free cash flow to debt coverage for Adial Pharmaceuticals Inc. Explore how well can Adial Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.27x | $-6.49 Million | $-6.49 Million | $1.52 Million | ▲ +39.9% |
| 2024 | -7.09x | $-6.92 Million | $-6.92 Million | $975.86K | — |
| 2023 | 0.00x | $0.00 | $-6.81 Million | $653.51K | ▲ +100.0% |
| 2022 | -4.55x | $-11.19 Million | $-11.19 Million | $2.46 Million | ▼ -58.1% |
| 2021 | -2.88x | $-11.88 Million | $-11.95 Million | $4.13 Million | ▲ +42.7% |
| 2020 | -5.03x | $-7.57 Million | $-7.63 Million | $1.51 Million | ▲ +56.8% |
| 2019 | -11.64x | $-6.27 Million | $-6.34 Million | $539.05K | ▼ -23.4% |
| 2018 | -9.43x | $-2.43 Million | $-2.50 Million | $257.97K | ▼ -1867.6% |
| 2017 | -0.48x | $-494.86K | $-494.86K | $1.03 Million | ▲ +55.4% |
| 2016 | -1.08x | $-274.38K | $-274.38K | $255.02K | ▲ +87.7% |
| 2015 | -8.76x | $-465.22K | $-465.22K | $53.08K | — |